FDA Inspection 1208162 — Keyur M. Brahme, MD
The FDA completed an inspection of Keyur M. Brahme, MD on May 30, 2023 in Vadodara. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 30, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vadodara (India)
Additional Details
Clinical BA/BE